# FDA drug recall: Naropin (ropivacaine hydrochloride Injection, USP), 0.5%, 100 mg per 20 mL (5 mg per mL), Twenty-five, 20 mL Single-Dose

> recall · VERIFIED · 2026-07-16

Firm: Fresenius Kabi USA, LLC · Class II · Presence of Particulate Matter: Hair was found in products

- Company: Fresenius Kabi USA, LLC
- Sector: therapeutics
- Primary source: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.